Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio.
Industry, Sector and Symbol
Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
Phone513-762-6690
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.78 billion
Profitability
Miscellaneous
Employees15,707
Next Earnings Date7/24/2019 (Estimated)
OptionableOptionable
Chemed (NYSE:CHE) Frequently Asked Questions
What is Chemed's stock symbol?
Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."
How often does Chemed pay dividends? What is the dividend yield for Chemed?
Chemed announced a quarterly dividend on Monday, May 20th. Stockholders of record on Thursday, May 30th will be given a dividend of $0.30 per share on Wednesday, June 19th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend is Wednesday, May 29th. View Chemed's Dividend History.
How will Chemed's stock buyback program work?
Chemed declared that its board has initiated a stock buyback plan on Wednesday, March 7th 2018, which allows the company to repurchase $150,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's leadership believes its shares are undervalued.
How were Chemed's earnings last quarter?
Chemed Co. (NYSE:CHE) issued its quarterly earnings results on Monday, April, 29th. The company reported $2.92 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $2.96 by $0.04. The business earned $462.03 million during the quarter, compared to the consensus estimate of $468.28 million. Chemed had a return on equity of 35.19% and a net margin of 11.37%. The business's revenue was up 5.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.72 earnings per share. View Chemed's Earnings History.
When is Chemed's next earnings date?
What guidance has Chemed issued on next quarter's earnings?
Chemed issued an update on its FY19 earnings guidance on Monday, April, 29th. The company provided earnings per share (EPS) guidance of $12.65-12.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.78. Chemed also updated its FY 2019 guidance to $12.65-12.85 EPS.
What price target have analysts set for CHE?
3 brokers have issued 12-month price objectives for Chemed's stock. Their forecasts range from $318.00 to $390.00. On average, they expect Chemed's stock price to reach $359.3333 in the next twelve months. This suggests a possible upside of 5.6% from the stock's current price. View Analyst Price Targets for Chemed.
What is the consensus analysts' recommendation for Chemed?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.
Has Chemed been receiving favorable news coverage?
Press coverage about CHE stock has been trending somewhat positive recently, according to InfoTrie. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Chemed earned a news sentiment score of 1.5 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days.
Who are some of Chemed's key competitors?
What other stocks do shareholders of Chemed own?
Who are Chemed's key executives?
Chemed's management team includes the folowing people:
- Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
- Mr. David P. Williams, Exec. VP & CFO (Age 58)
- Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
- Mr. Spencer S. Lee, Exec. VP (Age 63)
- Mr. Nicholas Michael Westfall, Exec. VP (Age 40)
Who are Chemed's major shareholders?
Chemed's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.38%), Neuberger Berman Group LLC (4.09%), Acadian Asset Management LLC (3.43%), Riverbridge Partners LLC (2.72%), FMR LLC (1.96%) and Renaissance Technologies LLC (1.69%). Company insiders that own Chemed stock include David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice. View Institutional Ownership Trends for Chemed.
Which institutional investors are selling Chemed stock?
CHE stock was sold by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, Riverbridge Partners LLC, Bank of Montreal Can, Boston Partners, Acadian Asset Management LLC, Natixis, Gabelli Funds LLC and Robeco Institutional Asset Management B.V.. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice. View Insider Buying and Selling for Chemed.
Which institutional investors are buying Chemed stock?
CHE stock was acquired by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, AJO LP, Northern Trust Corp, Ellis Investment Partners LLC, Ellis Investment Partners LLC, FMR LLC, Los Angeles Capital Management & Equity Research Inc. and Fort Washington Investment Advisors Inc. OH. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.
How do I buy shares of Chemed?
Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemed's stock price today?
One share of CHE stock can currently be purchased for approximately $340.31.
How big of a company is Chemed?
Chemed has a market capitalization of $5.42 billion and generates $1.78 billion in revenue each year. The company earns $205.54 million in net income (profit) each year or $11.93 on an earnings per share basis. Chemed employs 15,707 workers across the globe.
What is Chemed's official website?
How can I contact Chemed?
Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.
MarketBeat Community Rating for Chemed (NYSE CHE)
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
